[Oestriol effect upon prolactinaemia in postmenopausal women (author's transl)].
Six postmenopausal women were treated at two ocasions with an oral dose of, respectively, 2 mg and 6 mg oestriol per day for 14 days; at least one month interval separated the two treatment periods. Blood was collected for prolactin measurement (homologous human radioimmunoassay) every other day during each treatment period as well as during a 14 days control period in the same subjects. Mean prolactin level during oestriol administration, regardless of the dose, was statistically not significantly different from that observed during the control period.
D000284:Administration, Oral; D000328:Adult; D004964:Estriol / Q000008:administration & dosage* / Q000494:pharmacology; D005260:Female; D006801:Humans; D008593:Menopause / Q000187:drug effects*; D011388:Prolactin / Q000097:blood*
D011388:Prolactin; D004964:Estriol
Effet de l'oestriol sur la prolactinémie de la femme ménopausée.